Absci Corp (ABSI) stock
ABSINasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
$8.18+0.60 (+7.92%)
Close on Nov 18, 2026Market cap $1.40BP/E –Yield –
Absci operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Absci's operating income for the twelve months ending Jun 30, 2026 was -$126.20M. For fiscal 2025 it was -$120.32M. The highest annual figure on record is -$13.30M in fiscal 2020.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$120.32M | – |
| FY2024 | Dec 31, 2024 | -$108.89M | – |
| FY2023 | Dec 31, 2023 | -$115.52M | – |
| FY2022 | Dec 31, 2022 | -$106.75M | – |
| FY2021 | Dec 31, 2021 | -$75.24M | – |
| FY2020 | Dec 31, 2020 | -$13.30M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$34.16M | – |
| Q1 FY2026 | Mar 31, 2026 | -$30.85M | – |
| Q4 FY2025 | Dec 31, 2025 | -$31.04M | – |
| Q3 FY2025 | Sep 30, 2025 | -$30.15M | – |
| Q2 FY2025 | Jun 30, 2025 | -$31.39M | – |
| Q1 FY2025 | Mar 31, 2025 | -$27.73M | – |
| Q4 FY2024 | Dec 31, 2024 | -$29.77M | – |
| Q3 FY2024 | Sep 30, 2024 | -$28.90M | – |
| Q2 FY2024 | Jun 30, 2024 | -$26.72M | – |
| Q1 FY2024 | Mar 31, 2024 | -$23.50M | – |
| Q4 FY2023 | Dec 31, 2023 | -$24.74M | – |
| Q3 FY2023 | Sep 30, 2023 | -$23.30M | – |
| Q2 FY2023 | Jun 30, 2023 | -$42.99M | – |
| Q1 FY2023 | Mar 31, 2023 | -$24.49M | – |
| Q4 FY2022 | Dec 31, 2022 | -$21.09M | – |
| Q3 FY2022 | Sep 30, 2022 | -$27.97M | – |
| Q2 FY2022 | Jun 30, 2022 | -$28.89M | – |
| Q1 FY2022 | Mar 31, 2022 | -$28.80M | – |
| Q4 FY2021 | Dec 31, 2021 | -$26.26M | – |
| Q3 FY2021 | Sep 30, 2021 | -$21.14M | – |
| Q2 FY2021 | Jun 30, 2021 | -$16.69M | – |
| Q1 FY2021 | Mar 31, 2021 | -$11.15M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.63M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.36M | – |
| Q2 FY2020 | Jun 30, 2020 | -$2.81M | – |
See a number that looks wrong?